Fig. 5From: Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysisProbabilistic sensitivity analysis for the test strategy compared with the usual care: contribution of baseline parameter variability to overall model variabilityBack to article page